Market witnessed bullishness in the initial trading session mainly on the back of favourable cues on the domestic front.

The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019

The USFDA warning letter will not affect the existing business of Cadila Healthcare in the US and the existing product supplies from the Moraiya facility will continue

Dr Reddy's CFO Saumen Chakraborty attributed much of the challenges in the US market to price erosion and lower volumes

According to official data, the Air Quality Index in Delhi and surrounding areas of Noida, Ghaziabad, Gurugram and Faridabad region crossed the 500 mark and entered into Severe Plus / Emergency Category

The unions said ensuring \"proper governance in the system\" and \"removing political interference\" will address the problem of NPAs that has been weakening the financial health of the PSBs

Even though majority (57 per cent) think content censorship in important, many (36 per cent) believe regulation should only be for mass mediums like TV and films but not for online mediums

Dr. Reddy's Lab Q2 results: Consolidated revenue during July-September quarter of this fiscal rose by 26.41 per cent to Rs 4,800.9 crore as against Rs 3,797.8 crore in the year-ago period

Sixteen CEOs and economists lay out a roadmap to revive the economy

The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight

The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.

The move comes after the USFDA asked the company to test the drug for indications of N-nitrosodimethylamine (NDMA) impurity, which the regulator says is a 'probable human carcinogen'

Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities

Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India

Huawei, the world's biggest maker of such gear, is at the centre of a geopolitical tug-of-war between China and the United States

Analysts expect a better show in Q1 thanks to a combination of factors such as overall business improvement in the Unites States and a pick-up in demand in the domestic market.

Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years